FMP

FMP

Enter

CRMD - CorMedix Inc.

Profile of CorMedix Inc.(CRMD), CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic pr

About

ceo

Mr. Joseph Todisco MBA

sector

Healthcare

industry

Biotechnology

website

https://www.cormedix.com

exchange

NASDAQ

Description

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.

CIK

0001410098

ISIN

US21900C3088

CUSIP

21900C308

Address

300 Connell Drive

Phone

908 517 9500

Country

US

Employee

40

IPO Date

May 13, 2010

Key Executives

page loading card
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep